GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
1,471
14.3%
14.5%
Fillers & Biostimulators
1,014
1,101
8.0%
8.5%
Dermatological Skincare
1,331
1,449
9.3%
8.9%
Therapeutic Dermatology
780
1,185
50.2%
52.0%
of which Nemluvio
2
=*=*=*=*=*=
当前为第27/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页